Influence of subcutaneous specific immunotherapy on drug costs in children suffering from allergic asthma

Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma

(2012) Jasmina I. Ivanova et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Factors associated with patient visits to the emergency department for asthma therapy

(2012) Hamdan AL-Jahdali et al.   BMC Pulmonary Medicine

Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany

(2012) K.Y. Westerhout et al.   JOURNAL OF MEDICAL ECONOMICS

Children and adolescents’ health-related quality of life in relation to eczema, asthma and hay fever: results from a population-based cross-sectional study

(2011) Uwe Matterne et al.   QUALITY OF LIFE RESEARCH

Current Control and Future Risk in Asthma Management

(2011) Erika J Sims et al.   Allergy Asthma & Immunology Research

Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma

(2010) Bernd Brüggenjürgen et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: A randomized controlled trial

(2010) Stefan Zielen et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

(2009) Tmirah Haselkorn et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study

(2008) E. D. Bateman et al.   ALLERGY

Global strategy for asthma management and prevention: GINA executive summary

(2008) E. D. Bateman et al.   EUROPEAN RESPIRATORY JOURNAL